OM - Outset Medical Inc logo

OM

Outset Medical Inc

Outset Medical develops the Tablo Hemodialysis System for efficient kidney care, integrating water purification and dialysate production in a compact console. It serves health providers and patients, offering consumables and data analytics platforms for improved outcomes.

⚕️ Healthcare NASDAQ Listed 2020 $ USD
$1,000 invested 5 years ago $8today

Score Overview

1 Year
Score
Net Growth8.33%
Net TrendGrew
Net Income Consistency
Rev Growth-1.58%
Rev TrendShrank
Revenue Consistency
5 Years
Score5.2
Net Growth43.27%
Net Trend60%
Net Income Consistency
Rev Growth14.60%
Rev Trend60%
Revenue Consistency
All Time
Score
Net Growth37.99%
Net Trend50%
Net Income Consistency
Rev Growth135.48%
Rev Trend67%
Revenue Consistency

See the full market ranking →

Outset Medical Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 49M to $ 119M and net income went from -$ 120M to -$ 81M. Revenue increased in 3 of those 5 years; net income in 3.

Outset Medical Inc currently holds a 5-year HDB Score of 5.2 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 4.50
1 Year2025-08-12
$ 12.67-64.48%
5 Years2021-08-12
$ 569.70-99.21%
All Time2020-09-15
$ 910.20-99.51%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 117M-$ 74M$ 156M
2025$ 119M-$ 81M$ 168M
2024$ 113M-$ 127M$ 158M
2023$ 130M-$ 172M$ 203M
2022$ 115M-$ 162M$ 287M
2021$ 102M-$ 131M$ 339M
IPO2020$ 49M-$ 120M$ 314M

Explore beyond OM

You're looking at Outset Medical Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies